Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Read More 6 minute read Healthcare Industry News Lunit submits FDA filing for AI mammography model: What’s next for U.S. breast cancer screening? Find out how Lunit’s FDA-bound artificial intelligence risk model could change breast cancer screening and prevention in the United States. Read the full story. bySrinathDecember 8, 2025